| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.00046 |
1 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.00035 |
1 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00033 |
1 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.0003 |
1 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.00031 |
1 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.00023 |
1 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.0002 |
1 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
8.9e-05 |
1 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-7.4e-05 |
1 |
| mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
4.9e-05 |
1 |